Filing Details
- Accession Number:
- 0001104659-21-076535
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-03 18:58:03
- Reporting Period:
- 2021-06-01
- Accepted Time:
- 2021-06-03 18:58:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1442836 | Mersana Therapeutics Inc. | MRSN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1553053 | M Lawrence Alleva | C/O Mersana Therapeutics, Inc. 840 Memorial Drive Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-01 | 1,035 | $14.38 | 2,120 | No | 4 | P | Indirect | Held by Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Held by Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 0 | Direct |
Footnotes
- In a Form 4 filed on June 3, 2020, the reporting person reported direct beneficial ownership of 1,085 shares of the Company's common stock. Such shares are held directly by the Lawrence M. Alleva Revocable Trust and the nature of the reporting person's interest in such shares is indirect.
- The securities are held directly by the Lawrence M. Alleva Revocable Trust.